Sale of 215 shares at $39.8602 per share.
Reporting Person Ceesay Abraham · Officer Title Chief Executive Officer · Transaction Code S
Traded Sep 23, 2026 · Disclosed Sep 24, 2026
Source: SEC Form 4 · 0001193125-26-401017 · filed 2026-09-24 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Rapport Therapeutics, Inc. (RAPP)." Disclosed 2026-09-24. https://desqlong.com/cards/0001193125-26-401017-2 (retrieved 2026-09-26).